cardinal health inc. - CAH

CAH

Close Chg Chg %
222.05 -0.77 -0.35%

Closed Market

221.28

-0.77 (0.35%)

Volume: 1.22M

Last Updated:

Sep 23, 2026, 3:59 PM EDT

Company Overview: cardinal health inc. - CAH

CAH Key Data

Open

$222.22

Day Range

220.96 - 225.64

52 Week Range

145.87 - 258.30

Market Cap

$52.50B

Shares Outstanding

232.58M

Public Float

231.99M

Beta

0.52

Rev. Per Employee

N/A

P/E Ratio

31.22

EPS

$7.27

Yield

92.23%

Dividend

$0.52

EX-DIVIDEND DATE

Oct 1, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.66M

 

CAH Performance

1 Week
 
-1.82%
 
1 Month
 
-3.59%
 
3 Months
 
-7.00%
 
1 Year
 
43.95%
 
5 Years
 
332.25%
 

CAH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

About cardinal health inc. - CAH

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Specialty Solutions Segment and Global Medical Products and Distribution Segment. The Pharmaceutical and Specialty Solutions Segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States. The Global Medical Products and Distribution Segment manufactures, sources, and distributes Cardinal Health brand medical, surgical, and laboratory products, which are sold in the United States, Canada, Europe, Asia, and other markets. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

CAH At a Glance

Cardinal Health, Inc.
7000 Cardinal Place
Dublin, Ohio 43017
Phone 1-614-757-5000 Revenue 254.23B
Industry Medical Distributors Net Income 1.71B
Sector Distribution Services 2026 Sales Growth 14.223%
Fiscal Year-end 06 / 2027 Employees 63,900
View SEC Filings

CAH Valuation

P/E Current 31.164
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 32.848
Price to Sales Ratio 0.221
Price to Book Ratio N/A
Price to Cash Flow Ratio 10.88
Enterprise Value to EBITDA 14.586
Enterprise Value to Sales 0.242
Total Debt to Enterprise Value 0.162

CAH Efficiency

Revenue/Employee 3,978,591.549
Income Per Employee 26,823.161
Receivables Turnover 18.403
Total Asset Turnover 4.605

CAH Liquidity

Current Ratio 0.883
Quick Ratio 0.489
Cash Ratio 0.111

CAH Profitability

Gross Margin 3.696
Operating Margin 1.284
Pretax Margin 0.855
Net Margin 0.674
Return on Assets 3.104
Return on Equity N/A
Return on Total Capital 24.26
Return on Invested Capital 31.647

CAH Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 140.807
Total Debt to Total Assets 17.362
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 111.323
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cardinal Health Inc. - CAH

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
205.00B 226.83B 222.57B 254.23B
Sales Growth
+13.04% +10.65% -1.87% +14.22%
Cost of Goods Sold (COGS) incl D&A
198.40B 219.67B 214.72B 244.84B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
692.00M 710.00M 790.00M 956.00M
Depreciation
411.00M 446.00M 487.00M 595.00M
Amortization of Intangibles
281.00M 264.00M 303.00M 361.00M
COGS Growth
+13.29% +10.72% -2.26% +14.03%
Gross Income
6.60B 7.15B 7.86B 9.40B
Gross Income Growth
+5.96% +8.36% +9.83% +19.62%
Gross Profit Margin
+3.22% +3.15% +3.53% +3.70%
2023 2024 2025 2026 5-year trend
SG&A Expense
4.83B 5.00B 5.38B 6.13B
Research & Development
- - - -
-
Other SG&A
4.83B 5.00B 5.38B 6.13B
SGA Growth
+6.06% +3.46% +7.66% +13.93%
Other Operating Expense
- - - -
-
Unusual Expense
1.02B 933.00M 187.00M 801.00M
EBIT after Unusual Expense
749.00M 1.22B 2.29B 2.46B
Non Operating Income/Expense
(16.00M) 48.00M 27.00M 59.00M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
95.00M 67.00M 212.00M 348.00M
Interest Expense Growth
-44.77% -29.47% +216.42% +64.15%
Gross Interest Expense
95.00M 67.00M 212.00M 348.00M
Interest Capitalized
- - - -
-
Pretax Income
638.00M 1.20B 2.10B 2.17B
Pretax Income Growth
+182.96% +88.24% +74.94% +3.47%
Pretax Margin
+0.31% +0.53% +0.94% +0.86%
Income Tax
376.00M 348.00M 532.00M 469.00M
Income Tax - Current - Domestic
323.00M 373.00M 207.00M 287.00M
Income Tax - Current - Foreign
84.00M 79.00M 82.00M 91.00M
Income Tax - Deferred - Domestic
5.00M (77.00M) 244.00M 89.00M
Income Tax - Deferred - Foreign
(36.00M) (27.00M) (1.00M) 2.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
262.00M 853.00M 1.57B 1.71B
Minority Interest Expense
1.00M 1.00M 8.00M (9.00M)
Net Income
261.00M 852.00M 1.56B 1.71B
Net Income Growth
+127.97% +226.44% +83.22% +9.80%
Net Margin Growth
+0.13% +0.38% +0.70% +0.67%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
261.00M 852.00M 1.56B 1.71B
Preferred Dividends
- - - -
-
Net Income Available to Common
261.00M 852.00M 1.56B 1.71B
EPS (Basic)
1 3.4776 6.4772 7.2627
EPS (Basic) Growth
+129.90% +247.76% +86.25% +12.13%
Basic Shares Outstanding
261.00M 245.00M 241.00M 236.00M
EPS (Diluted)
0.9962 3.4494 6.4504 7.2321
EPS (Diluted) Growth
+129.79% +246.26% +87.00% +12.12%
Diluted Shares Outstanding
262.00M 247.00M 242.00M 237.00M
EBITDA
2.46B 2.86B 3.26B 4.22B
EBITDA Growth
+2.67% +16.38% +13.97% +29.33%
EBITDA Margin
+1.20% +1.26% +1.47% +1.66%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 273.133
Number of Ratings 22 Current Quarters Estimate 2.944
FY Report Date 09 / 2026 Current Year's Estimate 12.544
Last Quarter’s Earnings 2.91 Median PE on CY Estimate N/A
Year Ago Earnings 11.26 Next Fiscal Year Estimate 14.093
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 16 19 17
Mean Estimate 2.94 3.12 12.54 14.09
High Estimates 3.09 3.37 12.74 14.90
Low Estimate 2.88 3.01 11.97 13.15
Coefficient of Variance 2.28 2.60 1.19 2.44

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 15 14 14
OVERWEIGHT 2 4 4
HOLD 5 3 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Buy Buy

Cardinal Health Inc. in the News